Document is current
Any future updates will be listed below
-
Authors
Boursiquot, Jean-Nicolas
Gagnon, Rémi
Quirt, Jaclyn
Ellis, Anne K.
- License Information
-
More Information
Article History
Received: 10 October 2024
Accepted: 15 November 2024
First Online: 16 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Jean-Nicolas Boursiquot has received consulting fees or honoraria for continuing education from AstraZeneca, Pfizer, Medexus and Bausch & Lomb.Dr. Rémi Gagnon has served as a speaker and/or advisor for ALK-Abello, AstraZeneca, Aralez, CSL Behring, GlaxoSmithKline, Merck, Novartis, Pediapharm, Pfizer, Sanofi, and Shire and as an investigator for AstraZeneca, Biocryst, DBV, GlaxoSmithKline, Green Cross Pharmaceuticals, Merck, Novartis, Regeneron, Shire, Stallergenes, and Sanofi Genzyme/Regeneron.Dr. Jaclyn Quirt has participated in advisory boards for Aralez and Sanofi.Dr. Anne K. Ellis has participated in advisory boards for ALK-Abello, AstraZeneca, Bausch Health, LEO Pharma, Miravo, Merck, Novartis, has been a speaker for ALK-Abello, AstraZeneca, Bausch, Miravo, Medexus, Mylan, Novartis, Pfizer, Sanofi, StallergenesGreer and Regeneron. Her institution has received research grants from ALK Abello, Aralez, AstraZeneca, Bayer LLC, Medexus, Novartis, Sanofi and Regeneron. She has also served as an independent consultant to Bayer LLC, Pharming, and Regeneron.
: This article has been published as part of Allergy, Asthma & Clinical Immunology, Volume 20 Supplement 03, 2024: Practical Guide for Allergy and Immunology in Canada 2024. The full contents of the supplement are available at
